Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.96)
# 702
Out of 5,182 analysts
509
Total ratings
45.18%
Success rate
12.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $73 → $169 | $152.54 | +10.79% | 22 | Apr 14, 2026 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $12 | $2.17 | +453.00% | 18 | Apr 14, 2026 | |
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $10.66 | +87.62% | 6 | Apr 13, 2026 | |
| REPL Replimune Group | Downgrades: Sell | n/a | $2.28 | - | 21 | Apr 13, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $32 | $16.97 | +88.57% | 23 | Apr 10, 2026 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $9 | $2.20 | +309.09% | 16 | Apr 7, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $25 | $10.28 | +143.19% | 29 | Apr 2, 2026 | |
| BNTX BioNTech SE | Maintains: Buy | $140 → $130 | $99.47 | +30.69% | 47 | Mar 31, 2026 | |
| AKTS Aktis Oncology | Maintains: Buy | $30 → $33 | $18.09 | +82.42% | 2 | Mar 31, 2026 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $40 → $42 | $23.72 | +77.07% | 6 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $10.04 | +49.40% | 12 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $56 | $43.95 | +27.42% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $8 | $8.56 | -6.54% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $27 | $7.92 | +240.91% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $19 | $15.49 | +22.66% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.37 | +83.07% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $4.38 | +196.80% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $27 | $4.51 | +498.67% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.20 | +209.52% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $11.78 | +44.31% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.91 | +42.57% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $44 | $29.41 | +49.61% | 12 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $29 | $9.39 | +208.84% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $27 | $25.33 | +6.59% | 13 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $46 | $27.73 | +65.89% | 24 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $54 | $44.28 | +21.95% | 15 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.07 | +225.73% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.70 | +488.24% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $4.82 | +252.70% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $14.95 | +80.60% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $36.32 | +43.17% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $3.52 | -43.18% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.29 | +287.60% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $5.52 | -9.42% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.87 | +248.43% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.41 | +254.61% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.24 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $14.27 | +1,301.54% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.27 | +88,591.80% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.39 | +38,559.79% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.56 | +141.23% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $2.18 | +2,064,120.18% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.49 | +772.48% | 1 | Jan 7, 2021 |
Revolution Medicines
Apr 14, 2026
Maintains: Buy
Price Target: $73 → $169
Current: $152.54
Upside: +10.79%
Allogene Therapeutics
Apr 14, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $2.17
Upside: +453.00%
Telix Pharmaceuticals
Apr 13, 2026
Reiterates: Buy
Price Target: $20
Current: $10.66
Upside: +87.62%
Replimune Group
Apr 13, 2026
Downgrades: Sell
Price Target: n/a
Current: $2.28
Upside: -
Nurix Therapeutics
Apr 10, 2026
Reiterates: Buy
Price Target: $32
Current: $16.97
Upside: +88.57%
Caribou Biosciences
Apr 7, 2026
Reiterates: Buy
Price Target: $9
Current: $2.20
Upside: +309.09%
ORIC Pharmaceuticals
Apr 2, 2026
Reiterates: Buy
Price Target: $25
Current: $10.28
Upside: +143.19%
BioNTech SE
Mar 31, 2026
Maintains: Buy
Price Target: $140 → $130
Current: $99.47
Upside: +30.69%
Aktis Oncology
Mar 31, 2026
Maintains: Buy
Price Target: $30 → $33
Current: $18.09
Upside: +82.42%
Bicara Therapeutics
Mar 31, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $23.72
Upside: +77.07%
Mar 30, 2026
Reiterates: Buy
Price Target: $15
Current: $10.04
Upside: +49.40%
Mar 26, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $43.95
Upside: +27.42%
Mar 25, 2026
Maintains: Buy
Price Target: $15 → $8
Current: $8.56
Upside: -6.54%
Mar 23, 2026
Maintains: Buy
Price Target: $50 → $27
Current: $7.92
Upside: +240.91%
Mar 23, 2026
Maintains: Buy
Price Target: $14 → $19
Current: $15.49
Upside: +22.66%
Mar 23, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.37
Upside: +83.07%
Mar 23, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $4.38
Upside: +196.80%
Mar 16, 2026
Maintains: Buy
Price Target: $34 → $27
Current: $4.51
Upside: +498.67%
Mar 16, 2026
Reiterates: Buy
Price Target: $13
Current: $4.20
Upside: +209.52%
Mar 13, 2026
Maintains: Buy
Price Target: $13 → $17
Current: $11.78
Upside: +44.31%
Mar 13, 2026
Reiterates: Buy
Price Target: $7
Current: $4.91
Upside: +42.57%
Mar 6, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $29.41
Upside: +49.61%
Mar 6, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $9.39
Upside: +208.84%
Mar 6, 2026
Maintains: Buy
Price Target: $13 → $27
Current: $25.33
Upside: +6.59%
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $46
Current: $27.73
Upside: +65.89%
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $44.28
Upside: +21.95%
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $3.07
Upside: +225.73%
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.70
Upside: +488.24%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $4.82
Upside: +252.70%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $14.95
Upside: +80.60%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $36.32
Upside: +43.17%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.52
Upside: -43.18%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $5.52
Upside: -9.42%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.87
Upside: +248.43%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.24
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $14.27
Upside: +1,301.54%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.27
Upside: +88,591.80%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.39
Upside: +38,559.79%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.56
Upside: +141.23%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $2.18
Upside: +2,064,120.18%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.49
Upside: +772.48%